RBFOX3
Basic information
Region (hg38): 17:79089345-79611051
Links
Phenotypes
GenCC
Source:
- epilepsy (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RBFOX3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 75 | 82 | ||||
missense | 100 | 104 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 10 | 10 | 3 | 23 | ||
non coding | 59 | 65 | ||||
Total | 0 | 0 | 111 | 137 | 9 |
Variants in RBFOX3
This is a list of pathogenic ClinVar variants found in the RBFOX3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-79090888-A-G | Idiopathic generalized epilepsy | Uncertain significance (Jan 20, 2023) | ||
17-79090897-A-T | Idiopathic generalized epilepsy | Likely benign (Aug 17, 2023) | ||
17-79094433-C-T | Idiopathic generalized epilepsy | Likely benign (Nov 12, 2022) | ||
17-79094434-G-A | Idiopathic generalized epilepsy | Likely benign (Dec 27, 2023) | ||
17-79094435-G-A | Idiopathic generalized epilepsy | Likely benign (Jun 13, 2022) | ||
17-79094438-C-T | Idiopathic generalized epilepsy | Likely benign (Dec 13, 2023) | ||
17-79094442-G-T | Idiopathic generalized epilepsy | Likely benign (Dec 06, 2022) | ||
17-79094445-C-T | Idiopathic generalized epilepsy | Uncertain significance (Aug 27, 2023) | ||
17-79094460-A-C | Idiopathic generalized epilepsy | Uncertain significance (Jul 15, 2020) | ||
17-79094461-A-G | Idiopathic generalized epilepsy | Uncertain significance (Aug 16, 2022) | ||
17-79094466-G-A | Idiopathic generalized epilepsy | Likely benign (Dec 23, 2023) | ||
17-79094470-G-A | Idiopathic generalized epilepsy | Uncertain significance (Jan 17, 2024) | ||
17-79094472-C-T | Idiopathic generalized epilepsy | Likely benign (Jan 15, 2024) | ||
17-79094473-G-A | Idiopathic generalized epilepsy | Uncertain significance (Jun 21, 2019) | ||
17-79094475-C-T | Idiopathic generalized epilepsy | Likely benign (Oct 18, 2023) | ||
17-79094476-G-A | Idiopathic generalized epilepsy | Uncertain significance (Jan 02, 2023) | ||
17-79094477-C-T | Idiopathic generalized epilepsy | Uncertain significance (Dec 02, 2022) | ||
17-79094484-G-A | Likely benign (Jun 19, 2018) | |||
17-79094499-C-T | Idiopathic generalized epilepsy | Likely benign (Jan 25, 2024) | ||
17-79094500-G-A | Idiopathic generalized epilepsy | Uncertain significance (Feb 04, 2022) | ||
17-79094500-G-C | Idiopathic generalized epilepsy | Uncertain significance (Nov 22, 2022) | ||
17-79094504-C-T | not specified | Uncertain significance (Nov 15, 2021) | ||
17-79094505-G-A | Idiopathic generalized epilepsy | Likely benign (Oct 14, 2022) | ||
17-79094514-G-A | Idiopathic generalized epilepsy | Likely benign (Dec 04, 2021) | ||
17-79094523-G-A | Idiopathic generalized epilepsy | Uncertain significance (Mar 03, 2020) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RBFOX3 | protein_coding | protein_coding | ENST00000415831 | 10 | 528124 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.998 | 0.00215 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.13 | 87 | 163 | 0.532 | 0.0000111 | 1963 |
Missense in Polyphen | 23 | 69.595 | 0.33048 | 770 | ||
Synonymous | -0.647 | 77 | 70.1 | 1.10 | 0.00000559 | 628 |
Loss of Function | 3.93 | 0 | 18.0 | 0.00 | 9.93e-7 | 218 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Pre-mRNA alternative splicing regulator. Regulates alternative splicing of RBFOX2 to enhance the production of mRNA species that are targeted for nonsense-mediated decay (NMD). {ECO:0000250|UniProtKB:Q8BIF2}.;
Intolerance Scores
- loftool
- rvis_EVS
- -0.14
- rvis_percentile_EVS
- 42.88
Haploinsufficiency Scores
- pHI
- hipred
- hipred_score
- ghis
- 0.706
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rbfox3
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- regulation of alternative mRNA splicing, via spliceosome;mRNA processing;nervous system development;RNA splicing
- Cellular component
- nucleus;cytoplasm;perikaryon
- Molecular function
- DNA binding;mRNA binding